The Atrial Flow Regulator (AFR) is an innovative cardiac implant which is designed to address the unmet medical needs of patients suffering from heart failure (HF) despite optimal medical therapy.

Reducing increased LAP with a percutaneous delivered device leading to an artificial interatrial left–right shunt is a novel strategy in patients with symptomatic HF. Three devices are currently investigated in clinical trials (Figure 1 and Table 1): Figure 1. Interatrial shunt devices. Table 1.

We report the feasibility and efficacy of the atrial flow regulator device (Occlutech) for left ventricular unloading in a 58-year-old patient receiving extracorporeal membrane oxygenation.

2023年6月7日 · What is the Atrial Flow Regulator? The Atrial Flow Regulator, AFR, is a device intended for the treatment of symptoms associated with heart failure in both heart failure patients with preserved (HFpEF) and reduced (HFrEF) ejection fraction.

The Atrial Flow Regulator (AFR) is a tiny device that can be used to keep the interatrial shunt open and maintains its size.The device has two disks with a central opening (fenestration or shunt) so that blood can flow through the AFR, from the left to the right side of the heart.

Keywords: atrial shunt device; diastolic dysfunction; heart failure; left atrial pressure.

2020年9月24日 · Emergency Use of Occlutech® Atrial Flow Regulator Device Facilitates Weaning From Veno-Arterial Extracorporeal Membrane Oxygenation in a Patient With Severe Pulmonary Arterial Hypertension

2020年6月21日 · Atrial Flow Regulator is a self-expandable a double-disc nitinol wire mesh construction allowing communication across the interatrial septum (Fig. 1). In contrast to V-wave and IASD, it is available in different sizes.

Reducing increased LAP with a percutaneous delivered device leading to an artificial interatrial left–right shunt is a novel strategy in patients with symptomatic HF. Three devices are currently investigated in clinical trials (Figure 1 and Table 1):

VA ECMO is the preferred mechanical support for patients in cardiogenic shock with biventricular failure, allowing tissue perfusion as a bridge to recovery with long-term mechanical circulatory support, or transplantation.3-5 However, retrograde flow from the femoral artery can induce increased afterload, left ventricular distension, and severe ...